DECAGLIM-MV2
Glimepiride 2 mg + Metformin 500 mg ER + Voglibose 0.2 mg
DECAGLIM-MV2
DECAGON PHARMACEUTICALS
- Dosage Form
- Tablets
- Packaging
- 10 x 10 Tablets / Blister Pack
Overview of DECAGLIM-MV2
DECAGLIM-MV2 Tablets combine Glimepiride (2 mg), Metformin Hydrochloride ER (500 mg), and Voglibose (0.2 mg). An advanced triple-combination formula designed for comprehensive management of severe postprandial hyperglycemia and baseline insulin resistance in Type 2 Diabetes.
Indicated for Type 2 Diabetes uncontrolled on dual combinations, patients with pronounced postprandial spikes, hyperinsulinemia, and high cardiovascular risk.
"DECAGLIM-MV2 — In the Management of Post Prandial Hyperglycemia in Type II Diabetes."
Clinical Evidence Context: Primary Focus: Severe Postprandial Hyperglycemia in Type 2 Diabetes Mellitus and Prevention of Vascular Complications.
Diabetic Care
Tablets
More in Diabetic Care
View categoryDECAGLIM-M1
Glimepiride 1 mg + Metformin Hydrochloride ER 500 mg
DECAGLIM-M2
Glimepiride 2 mg + Metformin Hydrochloride ER 500 mg
DECAGLIM-MV1
Glimepiride 1 mg + Metformin 500 mg ER + Voglibose 0.2 mg